About this trial
The purpose of this study is to understand the impact of palliative and ablative radiotherapy (RT) treatment on HRQOL in patients with metastatic disease using the electronic patient-reported outcome platform ONCOpatient. Data will be collected at 4 timepoints: at the pre-treatment, final treatment and 4-weeks and 3 months post-treatment.
Patient Profile
Participants 18 years or older, due to receive palliative intent radiotherapy with conventional or stereotactic body radiotherapy techniques, willing to complete questionnaires with a prognosis of at least 3 months.
Where’s this trial being run?
Cork University Hospital
Can I join this study / trial?
The first step we recommend is to talk to your doctor or the cancer trials team at your hospital. You can find contact details for cancer trials research units in Ireland here.
It’s also a good idea to print this page and bring it with you to your appointment. It can help guide the conversation and remind you of what to ask. You may also want to talk to your family or friends about your options, as they can offer support as you make decisions.
For more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | HRQOL |
|---|---|
| Number: | 24-101 |
| Full Title: | Understanding the impact of palliative and ablative radiotherapy (RT) on Health-Related Quality of Life (HRQOL) in patients with metastatic disease |
| Principal Investigator: | Prof Aisling Barry |
|---|---|
| Type: | In-House |
| Sponsor: | |
| Recruitment Started: |
Global: Ireland: |
| Global Recruitment Target: | 150 |
|---|---|
| Ireland Recruitment Target: | 150 |